Osnat Bairey

Ibrutinib as Initial Therapy for Patients with Chronic Lymphocytic Leukemia

Jan A. Burger, Alessandra Tedeschi, Paul M. Barr et al. · New England Journal of Medicine · 2015 · 1.5K citations · Full text

Long-term efficacy and safety of first-line ibrutinib treatment for patients with CLL/SLL: 5 years of follow-up from the phase 3 RESONATE-2 study

Jan A. Burger, Paul M. Barr, Tadeusz Robak et al. · Leukemia · 2019 · 447 citations · Full text

Up to 8-year follow-up from RESONATE-2: first-line ibrutinib treatment for patients with chronic lymphocytic leukemia 

Paul M. Barr, Carolyn Owen, Tadeusz Robak et al. · Blood Advances · 2022 · 246 citations · Full text

Ibrutinib Vs 9, Chronic Lymphocytic Leukemia, Immunology +16

Variations in clinical presentation, frequency of hemophagocytosis and clinical behavior of intravascular lymphoma diagnosed in different geographical regions

Andrés JM Ferreri, Giuseppina Dognini, Elı́as Campo et al. · Haematologica · 2007 · 182 citations · Full text

Role and prognostic significance of the Ki‐67 index in non‐Hodgkin's lymphoma

Adi Broyde, Olga Boycov, Yulia Strenov et al. · American Journal of Hematology · 2009 · 149 citations

Tumor Biology, Lymphoid Neoplasia, Ki‐67 Index +14